Best Ophthalmology Companies in Israel
The 57 best Ophthalmology companies in Israel in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Orasis Pharmaceuticals.
Fifty-seven Ophthalmology companies tracked in Israel, $390M in disclosed funding, zero unicorns — that's the honest snapshot of a sector that's quietly stacking momentum without a breakout name yet. Orasis Pharmaceuticals leads the board at $111M raised, ForSight Robotics follows at $65M, and the rest of the pack clusters well below that. The ophthalmology market is forecast to grow from $20.7B in 2022 to $23.2B by 2030 at a 6.4% CAGR, so the macro tailwind is real. Rising prevalence of eye disorders, higher healthcare spend, and a sharper public awareness around vision loss are all pushing demand up this decade.
What I find genuinely interesting is where the heat's collecting right now. Coverage across the sector is flat, but the sub-themes pulling attention are very specific: virtual eye hospitals, surgical centers, and care delivery infrastructure. NYU Ophthalmology's first virtual eye hospital launch signals exactly where the model is shifting, and Israel's device-heavy cohort, backed by names like BioLight and Docor, is well-positioned if you're tracking that convergence. So if you want to map who's funded and who's moving fastest this quarter, the directory below is where to start.
- Growth Foreseen for Ophthalmology Sector
Ranked: Best Ophthalmology companies in Israel
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | AdOM Developer of tear film imaging device for the diagnosis of dry eye disease | — | — | 11 | 2008 | Yoel Arieli Founder | — | — | — |
| 2 | Advanced Medical Technologies Pupil dilation device & self use ocular tonometer for the diagnosis of eye disorders | — | — | 100 | 2005 | Tomas Mendelsohn Chief Executive Officer | — | — | — |
| 3 | APX Ophthalmology Developing pupil expanding device | — | — | — | 2015 | Ehud Assia Co-Founder | — | 21 patents Intraocular lens stabilization and iris retraction devices for cataract surgery | — |
| 4 | BioLight Diagnostics and therapeutics for ophthalmology | — | — | — | 2005 | Suzana Nahum Zilberberg CEO | WordPressMySQLPHP+23 | — | — |
| 5 | biotechnology general Biotechnology General is a developer and manufacturer of human health care products. | — | — | 300 | 1980 | — | WordPressMySQLPHP+10 | — | 1 job opening |
| 6 | Eye-Sight Fitness Connected smart eyeglasses for presbyopia | — | — | — | 2016 | Kobi Dekel Co-Founder | — | — | — |
| 7 | EyeOP Intraocular Pressure (IOP) measurable system for the diagnosis of glaucoma | — | — | — | 2012 | Vadim Shmukler Co-Founder | — | — | — |
| 8 | Eyewise Diagnostics Eye measurement technology for vision correction | — | — | — | 2016 | Israel Manela Founder & CEO | — | — | — |
Top 12 Ophthalmology companies in Israel
#1
Series B · Yokneam Illit, Northern District · founded 2020 · 50 employees$65Mraised▾
Provider of an AI-based ophthalmic surgical robot for healthcare professionals. The company has developed a next-generation robotic platform that has features for image visualization, robotic microsurgical technology, and cognitive computing methods. The microsurgical instrument has been built to be used for delicate surgery procedures using AI-based technology.
- Jun 2025Series B$125M
- Apr 2022Series A$55M
- Mar 2021Series A$10M
#2
Series D · Herzliya, Tel Aviv · founded 2015 · 24 employees$111Mraised▾
Orasis Pharmaceuticals is developing reformulated eye drops for the treatment of Presbyopia. They are developing CSF-1 eye drops that assist in eliminating the use of eyeglasses. It is used as a topical solution directly to the eye which improves the elasticity of crystalline glasses. The candidate is in phase II clinical trials.
- Oct 2024Venture Debt$10M
- Oct 2024Series D$68M
- Sep 2020Series C$30M
- Jun 2018Series B$13M
#3
Series C · Kiryat Ono, Israel · founded 2012 · 8 employees$35Mraised▾
Provider of a surgical device for the treatment of glaucoma. It offers a minimally invasive microfluidic full-thickness procedure, guarded by the small diameter of the drainage channel, and uses a custom-made cutting and drilling device designed so as to reduce trauma to the surrounding tissue and therefore minimize scar tissue formation allowing for a long-lasting filtering bleb.
- Jul 2022Series C$35M
#4
Series C · Ness Ziona, Center District · founded 2011 · 19 employees$36Mraised▾
Developer of ophthalmic devices for the treatment of corneal edema. The Hyper-CL™ therapeutic contact lens for the treatment of corneal pathologies. Another product EndoArt is a polymer film implant that is attached to the posterior corneal surface to treat corneal edema secondary to endothelial dysfunction.
- Mar 2021Series C$25M
- Mar 2017Series A$6.5M
- Apr 2015Series A$3.6M
- Seed$700K
#5
Acquired · Yavne, Center District · founded 2013 · 20 employees$14.8Mraised▾
Developer of a laser device for the treatment of glaucoma. The company's device Vision DSLT offers non-invasive, non-contact, and painless laser therapy. This device delivers laser beam to the limbus which enhances intraocular fluid drainage and lowers the pressure. It helps in the treatment of open-angle glaucoma and angle-closure glaucoma.
- Jan 2022Grant (prize money)$2.8M
- Jul 2020Series B$12.2M
- Jun 2017Grant (prize money)$2.8M
- Jun 2017Series A$2.5M
#6
Series B · Lod, Central District · founded 2016 · 22 employees$20Mraised▾
Provider of eye-tracking-based solutions for vision assessment and treatment. It offers medical devices to prevent vision impairments among pediatric patients using eye-tracking-based technology in novel diagnostic, therapeutic, and preventive solutions. Its products include CureSight an amblyopia treatment system, designed to replace traditional eye patching, TrackSight a software-based vision health monitoring and myopia prevention system, and Eye swift an eye-tracking-based vision diagnostics system.
- Mar 2022Series B—
- Jul 2020Series A$8M
#7
Series C · Tel Aviv, Tel Aviv · founded 1997 · 11 employees$37.2Mraised▾
Azura Ophthalmics is developing therapies for meibomian gland dysfunction (MGD), an underlying cause of dry eye disease. It is working on a portfolio of compounds in combination with a novel drug delivery platform to advance a portfolio for the treatment of lid margin diseases like Meibomian gland dysfunction (MGD), Blepharitis and Contact Lens Discomfort. The company leading product AZR-MD-001 for MGD is in phase 2 of the clinical trial, while the other products like AZR-MD-002, AZR-MD-003 are in the pre-clinical stage.
#8
Deadpooled · Safed, North District · founded 2015$32Mraised▾
Tisbury Pharmaceuticals is a pre-clinical stage company focused on the developing therapeutics for primary open angle glaucoma. Its clinical candidate R-801 was licensed from its founding company Radikal Therapeutics (RTX). It is constructed by the fusion of 2 pharmacophores, a K+-ATP channel activating moiety that activates the ischemic preconditioning (IPC) response, and a pyrrolidine nitroxide moiety that serves as a mimetic of catalase and superoxide dismutase. The candidate accelerates flow via the trabecular meshwork redox catalysis and K+-ATP channel activation. The candidate maintains a strong IP and claims to has shown no apparent side-effects in its trials. Based in Israel, it has a US office at Beverly, MA.
- Jun 2017Series A$32M
#9
Deadpooled · Ness Ziona, Center District · founded 2008 · 6 employees$23Mraised▾
Regenera Pharma is an Israeli, clinical stage biopharma developing botanically-derived small molecule therapeutics for optic nerve disorders. Its lead candidate RPh201, an extract of Mastic Gum, is a G protein-coupled receptor (GPCR) antagonist which is currently in phase 2 study for Traumatic Neuropathy or Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). It is also planning to extend this product applications for the other neurodegenerative indications.
- Jan 2018Series A$20M
- May 2015Series A$3M
#10
Series C · Petah Tikva, Central District · founded 2011 · 20 employees$4Mraised▾
Developer of adaptive glasses utilizing liquid crystal lenses for vision correction. The technology dynamically corrects vision impairment, functioning similarly to the human eye. This allows the wearer to focus at various distances. The adaptive sunglasses can switch to reading glasses with a swipe.
- Nov 2022Series C—
- Feb 2016Series A$4M
#11
Series A · Ra anana, Center District · founded 2015 · 15 employees$4Mraised▾
Developer of nanotechnology-based artificial corneal implants. Its implant is a synthetic cornea that uses nano-cell technology and can be integrated with artificial optics. The product line includes CorNeat KPro and the CorNeat EverPatch for ophthalmic surgery practices in the areas of cornea, sclera, glaucoma (trabecular mesh), myopia, and more.
#12
Funding Raised · Zikhron Ya akov, Haifa District · founded 2016 · 10 employees$2.9Mraised▾
Developer of therapeutics for inflammatory ocular disease. The company's lead candidate TRS01 eye drops for uveitic glaucoma, and others include TRS02 intravitreal injection for diabetic macular edema, non-proliferative diabetic retinopathy, and dry age-related macular degeneration.
- Mar 2022Grant (prize money)$110K
- Jun 2021Grant (prize money)$59.5K
- Jul 2019Grant (prize money)$2.7M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Ophthalmology coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Medical Devices is moving in Israel
A read on the academic research around Medical Devices — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 34 Israel-affiliated papers.
- Tel Aviv University5
- Hadassah Medical Center5
- Hebrew University of Jerusalem5
- Ben-Gurion University of the Negev5
- Technion – Israel Institute of Technology4
- Surgical robot3
- Robot2
- Robotics2
- Nanotechnology1
- Biomedical engineering1
- MEDLINE3
- Robotics3
- Risk assessment3
- Robotic surgery2
- Robot2
- Surgical robot1→4
- Robot1→4
Where medical devices is researched across Israel
Location clusters by institution affiliation — each city's volume, stance tone, and a quick read on its hot topic, what's advancing, the opening opportunity, and the main concern.
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.